Finance

Lists
Why is MYGN down 2,86%?
Dive Deeper
MYGN:NASDAQ
Myriad Genetics Inc
4,08 $
-2,86%
(-0,12) 1D
4,08 $
0,00% (0,00)
After hours
Closed: 13 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MYGN...
Open
4,20 $
High
4,22 $
Low
4,05 $
Mkt. cap
390,25 մլն
Avg. vol.
2,04 մլն
Volume
1,38 մլն
52-wk high
8,59 $
52-wk low
2,74 $
EPS
-1,20 $
Beta
1,64
Shares outstanding
95,65 մլն
No. of employees
3 հզր
Open
4,20 $
High
4,22 $
Low
4,05 $
Mkt. cap
390,25 մլն
Avg. vol.
2,04 մլն
Volume
1,38 մլն
52-wk high
8,59 $
52-wk low
2,74 $
EPS
-1,20 $
Beta
1,64
Shares outstanding
95,65 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz
Employees2,7 հզր
Founded1991
HeadquartersՍոլթ Լեյք Սիթի, Յուտա, Միացյալ Նահանգներ
Sector-
Websitemyriad.com
Analyst ratings
Based on 8 analysts giving stock ratings to MYGN in the past 3 months
Hold
Buy
1
Hold
4
Sell
3
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for MYGN in the last 3 months.
Highest
Current 4,08 $
8,00 $ (+96,08%)
Average
3,83 $ (-6,13%)
Lowest
2,00 $ (-50,98%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Brennan
TD Cowen
Hold
Maintained
4,50 $
+10,3%
10/13/2026
William Bonello
Craig-Hallum
Buy
Maintained
8,00 $
+96,1%
10/02/2026
Unknown Analyst
UBS
Hold
Initiated
3,60 $
-11,8%
09/08/2026
Doug Schenkel
UBS
Hold
Maintained
3,60 $
-11,8%
09/09/2026
David Westenberg
Piper Sandler
Sell
Downgraded
2,00 $
-51%
09/01/2026
Unknown Analyst
Jefferies
Sell
Maintained
2,50 $
-38,7%
08/21/2026
Mason Carrico
Stephens
Hold
Reiterated
3,00 $
-26,5%
08/18/2026
Unknown Analyst
Guggenheim
Hold
Maintained
-
-
08/03/2026
Michael Ryskin
Bank of America Securities
Sell
Reiterated
3,20 $
-21,6%
08/03/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
3,00 $
-26,5%
08/02/2026
Kyle Boucher
TD Cowen
Hold
Reiterated
4,00 $
-2%
07/31/2026
Lu Li
UBS
Hold
Maintained
6,00 $
+47,1%
02/25/2026
Last report
30 հլս, 2026 թ.
Fiscal period
Q2 2026
-0,25 $ / -0,06 $
-332,68%miss
Revenue / Est. (USD)
190,70 մլն / 206,03 մլն
-7,44%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
205,70 մլն
209,80 մլն
200,40 մլն
190,70 մլն
Cost of goods sold
61,90 մլն
63,00 մլն
62,80 մլն
63,70 մլն
Cost of revenue
61,90 մլն
63,00 մլն
62,80 մլն
63,70 մլն
Research and development expenses
28,20 մլն
25,50 մլն
27,10 մլն
25,00 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
138,90 մլն
124,30 մլն
135,80 մլն
140,90 մլն
Operating expense
167,10 մլն
149,80 մլն
162,90 մլն
165,90 մլն
Total operating expenses
229,00 մլն
212,80 մլն
225,70 մլն
229,60 մլն
Operating income
-23,30 մլն
-3,00 մլն
-25,30 մլն
-38,90 մլն
Other non operating income
400,00 հզր
400,00 հզր
-
-
EBT including unusual items
-26,20 մլն
-8,90 մլն
-34,10 մլն
-42,60 մլն
EBT excluding unusual items
-26,20 մլն
-6,20 մլն
-28,70 մլն
-42,60 մլն
Income tax expense
1,20 մլն
-1,00 մլն
-
600,00 հզր
Effective tax rate
-4,58%
11,24%
-
-1,41%
Other operating expenses
-
-
-
-
Net income
-27,40 մլն
-7,90 մլն
-34,10 մլն
-43,20 մլն
Net profit margin
-13,32%
-3,77%
-17,02%
-22,65%
Earnings per share
-
0,04
-0,09
-0,25
Interest and investment income
500,00 հզր
800,00 հզր
700,00 հզր
400,00 հզր
Interest expense
-3,80 մլն
-4,40 մլն
-4,10 մլն
-4,10 մլն
Net interest expenses
-3,30 մլն
-3,60 մլն
-3,40 մլն
-3,70 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-10,70 մլն
9,60 մլն
-12,80 մլն
-26,40 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps